Olanzapine (OLZ) is one of the most globally prevalent atypical antipsychotics, clinically indicated for the treatment of schizophrenia, manic episodes, and the maintenance therapy of bipolar disorder.

AccuSift provides high-performance competitive antibody pairs for olanzapine detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 0.25 ng/mL